Drug intelligence / Profile preview

antibiotics + probiotics

Development stage
Unknown
Modality
Small Molecules, Yeast Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Bacterial Strains → Single Strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Defined Consortia → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics, Complex Communities → Multi-strain Products → Live Biotherapeutic Products → Microbiome Therapeutics
Administration
Oral
01

Overview

A therapeutic approach combining antibiotics with probiotics to mitigate the adverse effects of antibiotics on gut microbiota. Probiotics are administered alongside or following antibiotic treatment to help prevent antibiotic-associated diarrhea (AAD), reduce the risk of Clostridioides difficile infection, and support gut microbiome recovery. This combination has been shown in clinical trials to significantly reduce the incidence of antibiotic-associated diarrhea and improve gastrointestinal quality of life during antibiotic therapy. ## What Are Probiotics? Probiotics are beneficial microorganisms that, when administered in adequate amounts, confer health benefits to the host. In the context of antibiotic therapy, specific probiotic strains have been clinically studied for their ability to reduce antibiotic-associated side effects. ## Benefits of Taking Probiotics with Antibiotics Research indicates that taking probiotics alongside antibiotics can: - Reduce the risk of antibiotic-associated diarrhea (AAD) by approximately 42%[1][3] - Decrease the incidence of *Clostridioides difficile* (*C. diff*) infections by about 60%[8] - Help maintain gut microbiome diversity during antibiotic treatment[4] - Improve gastrointestinal quality of life during antibiotic therapy[5] - Enhance treatment outcomes for certain conditions like *Helicobacter pylori* infections[8] ## Most Effective Probiotic Strains Several probiotic strains have demonstrated efficacy when taken with antibiotics: - *Lactobacillus rhamnosus GG* (LGG)[6] - *Saccharomyces boulardii*[1][6] - *Lactobacillus acidophilus* Rosell-52[4] - *Lactobacillus rhamnosus* Rosell-11[4] - *Bifidobacterium lactis* Lafti B94[4] A high-dose, multistrain approach combining multiple *Lactobacillus* species, *Bifidobacterium* species, *Bacillus coagulans*, and *Saccharomyces boulardii* has shown significant efficacy in clinical trials[5]. ## When to Take Probiotics with Antibiotics For optimal results: - Some probiotic formulations can be taken at the same time as antibiotics[4] - Other probiotics should be taken at least 2 hours before or after antibiotics to avoid direct interaction[2] - Continue taking probiotics throughout the antibiotic course and preferably for at least one week after completing antibiotics[4] ## Who Benefits Most People who may benefit most from taking probiotics with antibiotics include: - Individuals over age 65 - Hospitalized patients - People with weakened immune systems - Those at high risk for *C. difficile* infections[6] ## Safety Considerations Probiotics are generally safe when taken with antibiotics, with minimal side effects reported in clinical trials. However, they should be used with caution in severely debilitated or immunocompromised individuals[1].

Brand names
Reuterin GGSinquanon

Beyond the preview

Go deeper on antibiotics + probiotics.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on antibiotics + probiotics.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call